WO1993004101A1 - Polyurethane foams - Google Patents

Polyurethane foams Download PDF

Info

Publication number
WO1993004101A1
WO1993004101A1 PCT/GB1992/001527 GB9201527W WO9304101A1 WO 1993004101 A1 WO1993004101 A1 WO 1993004101A1 GB 9201527 W GB9201527 W GB 9201527W WO 9304101 A1 WO9304101 A1 WO 9304101A1
Authority
WO
WIPO (PCT)
Prior art keywords
isocyanate
foam
ether
prepolymer
derived
Prior art date
Application number
PCT/GB1992/001527
Other languages
French (fr)
Inventor
Angela Noeleen O'reilly
Richard Milner
Michael Francis Shelvey
Original Assignee
Smith & Nephew Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith & Nephew Plc filed Critical Smith & Nephew Plc
Priority to GB9400982A priority Critical patent/GB2273296B/en
Priority to AU24404/92A priority patent/AU656997B2/en
Priority to EP92917631A priority patent/EP0599932A1/en
Priority to JP5504197A priority patent/JPH06510312A/en
Publication of WO1993004101A1 publication Critical patent/WO1993004101A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00Polymeric products of isocyanates or isothiocyanates
    • C08G18/06Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/70Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the isocyanates or isothiocyanates used
    • C08G18/72Polyisocyanates or polyisothiocyanates
    • C08G18/721Two or more polyisocyanates not provided for in one single group C08G18/73 - C08G18/80
    • C08G18/724Combination of aromatic polyisocyanates with (cyclo)aliphatic polyisocyanates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/26Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42Use of materials characterised by their function or physical properties
    • A61L15/425Porous materials, e.g. foams or sponges
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00Polymeric products of isocyanates or isothiocyanates
    • C08G18/06Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/28Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
    • C08G18/2805Compounds having only one group containing active hydrogen
    • C08G18/2815Monohydroxy compounds
    • C08G18/283Compounds containing ether groups, e.g. oxyalkylated monohydroxy compounds
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00Polymeric products of isocyanates or isothiocyanates
    • C08G18/06Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/28Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
    • C08G18/40High-molecular-weight compounds
    • C08G18/48Polyethers
    • C08G18/4833Polyethers containing oxyethylene units
    • C08G18/4837Polyethers containing oxyethylene units and other oxyalkylene units
    • C08G18/4841Polyethers containing oxyethylene units and other oxyalkylene units containing oxyethylene end groups
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G2110/00Foam properties
    • C08G2110/0008Foam properties flexible
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G2110/00Foam properties
    • C08G2110/0041Foam properties having specified density
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G2110/00Foam properties
    • C08G2110/0083Foam properties prepared using water as the sole blowing agent

Definitions

  • the present invention relates to hydrophilic polyurethane foams, blends used to prepare these foams, absorptive devices comprising the foams and methods for their preparation.
  • hydrophilic polyurethane foams for example as an absorbent material
  • hydrophilic polyurethane foams for example as an absorbent material
  • hydrophilic polyurethane foams are usually more expensive than the conventional cellulosic absorbent materials used in such devices and have therefore not been extensively used in commercial absorptive devices.
  • British Patent No. 1429711 see also United States Patent Nos.
  • 3812618, 3812619, 3874694, 3889417, 3928138, 3929574 and 4137200 discloses a hydrophilic polyurethane foam formed by reacting with water an isocyanate capped polyoxyethylene glycol prepolymer.
  • British Patent No. 2188055 discloses hydrophilic polyurethane foams formed by reacting with water the reaction product of polyisocyanate which has a functionality of greater than 2 and polyalkylene glycol mono alkyl or alkaryl ether. These prepolymers require to be mixed with only relatively low aaounts of water, thus obviating the need for an elaborate drying stage. The foams are therefore more economical to manufacture than previously known hydropilic foans.
  • reaction rates of aliphatic isocyanate based polyurethane foam systems tend to be undesirably slow for commerical use unless high levels of ethylene oxide containing residues are incorporated into the reactive system.
  • Such dressings need to be able to absorb aqueous materials such as wound exudate and to be produced quickly and economically to compare favourably with conventional fabric and pad dressings.
  • the present invention seeks to provide a polyurethane foam which is hydrophilic and has good dimensional stability when produced in thin flat sheets and which can be produced rapidly and economically.
  • the present invention provides a polyurethane hydrophilic foam, suitable for use as first aid dressing which and comprise residues of a aromatic isocyanate, of an aliphatic isocyanate, of a polyoxyalkylene monoether and of a polyoxyalkylene polyol such as a polyether polyol.
  • the present invention further provides an absorptive device which comprises a hydrophilic polyurethane foam of the invention.
  • the absorptive device of the invention is preferably a medical or hygienic device such as a vound dressing eg. a first aid dressing, sanitary towel, diaper, incontinence pad tampon, or the like.
  • the invention provides a process for preparing a hydrophilic polyurethane foam of the invention which comprises blending at least one aromatic based prepolymer with at least one aliphatic based prepolymer. An aqueous phase is then added to effect the foaming reaction and the foam formed is allowed to set.
  • a hydrophilic polyurethane foam comprising residues of a first isocyanate prepolymer derived from a polyoxyalkylene mono ether and an aromatic isocyanate containing at least two isocyanate groups and residues of a second isocyanate prepolymer derived from a polyoxyalkylene mono ether and an aliphatic isocyanate containing at least two isocyanate groups and in which at least one of said isocyanate prepolymers contains residues from a polyether polyol.
  • the present invention also provides a hydrophilic polyurethane foam formed by blending at least one of said aromatic isocyanate based prepolymers and at least one aliphatic isocyanate based prepolymers and subsequently adding an aqeous phase to catalyse the foaming reaction wherein at least one of the prepolymers is additionally derived from a polyether polyol .
  • control over a wider range of processing variables and foam properties can be achieved than was hitherto possible.
  • Processing variables which may re controlled more readily than was previously possible include efficiency of mixing and ease of dispensing, cre ⁇ m time, rise time, gel time and cure time.
  • Foam properties which may be controlled more readily according to the process of tie invention include softness and resiliency, density, cell size and structure, water content and capacity, linear swell on hydration and rate of wicking.
  • foams displaying excellent water uptake, water capacity and strength have been found.
  • the foams also possess a lower level of extractables. Furthermore they can be formed into tiin sheets which show excellent conformability.
  • the prepolymer blend should contain at least 10w/w% of the solids weight of aliphatic based prepolymer. Similarly it has been fc_nd that the blend should contain at least 10w/w% of the solids weight of aromatic based prepolymer. Aptly the ratio of aromatic isocyanate to aliphatic isocyanate prepolymers will be from 25-75 to 75:25 weight percent. More aptly the ratio of prepolymers will be about 50:50 weight percent.
  • the hydrophilic polyurethane foams of the invention can be formed by mixing the blend with a stoichiometric amount of water. It is preferred, however, to mix the blend with a low molar excess of water for example 10% by weight of water. It has been found that this low molar excess of water can be easily absorbed by the hydrophilic foam.
  • Suitable polyoxyalkylene mono ethers for preparing the prepolymer components of the blend of the present invention may be polyoxyalkylene monoalkyl or monoalkaryl ethers.
  • the mono ethers are polyalkylene glycol monoethers.
  • the alkylene moiety of the mono ethers may contain 1 to 4 carbons.
  • Preferred polyalkylene glycol mono alkaryl ethers are those in which the alkylene group is ethylene.
  • Suitable polyalkylene glycol mono alkaryl ethers include those in which the a-ryl moeity is phenyl.
  • Preferred ethers are those in which the alkyl moeity contains from 1 to 20 carbon atoms eg. octyl or nonyl.
  • Suitable polyalkylene glycol mono alkyl ethers for forming the reaction product are those in which the alkyl group contains 1 to 20 carbon atoms.
  • Alkylene favoured ethers are those in which the alkyl group is a methyl group.
  • Another class of preferred polyalkylene glycol mono alkyl ethers are those in which the alkyl group contains 10 to 18 carbon atoms, eg. lauryl or cetyl.
  • Preferred polyalkylene glycol mono alkyl ethers are those in which the alkylene group is ethylene.
  • the polyalkylene glycol alkyl or alkaryl ether can suitably have an average molecular weight of 180 to 6000.
  • Apt ethers are polyethylene glycol mono lauryl ethers having an average molecular weight of approximately 1090 and 360 known as Brij 35 and Brij 30 respectively, available from Honeywell Atlas and polyethylene glycol mono methyl ethers having an average molecular weight of approximately 500 and 5000 known as PEG monomethylether molecular weight 550 and 5000 respectively, available from Aldrich Chemicals.
  • Suitable polyethylene glycol mono nonyl phenyl ethers are commercially available under the Trade names Antarox CO-320, Antarox Co-990, available from GAF (Great England) Co. Ltd.
  • Apt polyethylene glycol mono nonyl phenyl ethers are Dowafax 9N6 and 9N20 having an average molecular wieght in the range of 400-500 and 1100-1200 respectively and available from K+K Greeft Ltd.
  • the ethylene oxide molecular weight can vary in the range 220 to 2200.
  • the polyethylene glycol mono alkyl or alkaryl ether used in the invention will normally contain water. It is preferred, however, that the ether contains less than 1% by weight water, to limit the number of urea groups formed in the reaction with the polyisocyanate during the prepolymer formulation.
  • the polyether polyol residues present in at least one of the blend prepolymers may be derived from polyhydric alcohols, alkylene polyamines, alkylene amines, cyclic amines, amides and polycarboxylic acids.
  • suitable polyols may be derived from hydrophilic reactant ⁇ .
  • a particularly suitable hydrophilic reactant is ethylene oxide.
  • Preferred polyether polyols are derived from ethylene oxide and aliphatic polyhydric alcohols. Suitable alcohols may have from 2 to £ carbon atoms eg. ethylene glycol, pentaerythritol, procylene glycol, 2,3-butylene glycol, glycerol, 1,5-per.oanediol and the like.
  • the polyether polyols may be derived from the polymerisation of ethylene oxide in _____ presence of the above mentioned di- or polyfunctional reactants.
  • polyether polyols for the preparation of foams of the present invention are polyether triols.
  • Preferred polyether triols are polyoxypropylene (PPG) ether triols, end-capped with polyethylene oxide (PEG).
  • PEG polyethylene oxide
  • the PEG may comprise 2 to 30w/w% of the polyether triol.
  • the PEG comprises 5 to 15w/w% of the rolyether.
  • Apt polyoxypropylene ether triols, end-capped with PEG have an average molecular weight of 700 to 7000.
  • the PPG ether triols, end capped with PEG will have an average molecular weight in the range of 3000-3500 eg. Arcol 132 available from Arco Chemical Products Europe.
  • At least one of the blend prepclymers may further be derived from a copolymer polyether triol derived from the polyether polyols described herein.
  • a particularly preferred copolymer polyether is based on PPG and PEG blocks.
  • the PEG may be present in the range of 40 to 75w/w of the copoljmer. More suitably the PEG may comprise 45-55w/v%.
  • the PEG comprises 45w/w% of the copolymer.
  • a preferred copolymer polyether is Voranol CP1421 which has an average molecular weight in the range of 3000-3500 and is supplied by Dow Chemicals Europe.
  • the ratio of triol equivalents _o mono ether equivalents may be varied to alter the processing variables and the foam properties. It has been found that suitably the ratio of triol equivalents to mono ether equivalents is in the range of 1.3:1 to 10:1, more suitably from 1:1 to 5:1 and preferably about 3:1.
  • the i ⁇ ocyanates used for forming the blend prepolymers will have a functionality of at least 2.
  • both the aliphatic aromatic isocyanates will have a functionality of less than about 2.5.
  • Suitable aliphatic polyisocyanates for use in the invention include 4 , 4 '-dicyclohexyl nethane di-isocyanate (Desraodur W) which has a functionality of 2.0 and is available from Bayer A.G. and hexamethylene di-isocyanate.
  • Suitable aromatic isocyanates for forming the blend prepolymers are polymeric methylene di-isocyanates.
  • Polymeric methylene di-isocyanates comprise a mixture of 4,4'-diphenyl methane diisocyanates and one or more of polyaeric homologues.
  • Apt polymeric methylene di-isocyanates are known as suprasec VM 10, VM 20 and VM 50 available from ICI and have a functionality of 2.07, 2.13 and 2.49 respectively.
  • aromatic isocyanates which may be used include toluene di-isocyanate, methylene-bis-( 4-phenyl isocyanate) , 3,3'-bitolylene-4,4'-di-isocyanate, 1,4-phenylene di-isocyanate, naphthalene-1,5-*-di-isoc ⁇ anate and the like.
  • a favoured blend for forming foams of the present invention comprises an aliphatic based prepolymer derived from polyoxyethylene glycol r ⁇ ono-nonyl phenyl ether, a polyoxypropylene ether triol, end-capped with PEG, a copolymer poplyether triol and 4,4'-dicyclohexyl methane di-isocyanate (Desm ⁇ dur W) .
  • the blend further comprises an aromatic based prepolymer derived from a polyoxyethylene gylcol mono-nonyl phenyl ether, a polyoxypropylene ether triol, end-capped with PEG and a polymeric methylene di-isocyanate comprising a mixture of , '-diphenyl methane di-isocyanate and one or more polymeric homologues.
  • the isocyanate and reactive hydrogen containing compound are present in an amount to ensure that the prepolymers contain an excess of isoycanate groups.
  • the isocyanate to hydroxyl ratio (NCO:OH) is at least 2:1.
  • the NCO:OH ratio should be less than 6:1.
  • the NCO:OH ratio is in the range of 2.7:1 and 4:1.
  • the prepolymers employed in the invention contain an excess of isocyanate groups.
  • they contain an excess of at least 2 w/w% NCO groups, more suitably upto 12%w/w excess NCO groups.
  • the prepolymers contain an excess of 5 tc 7w/w% NCO groups.
  • the mono ethers and pclyols will be pre-dried to a water content of less than 1%.
  • the blend can be reacted with an aqueous phase to form a hydrophilic polyurethane foam of the invention.
  • the hydrophilic polyurethane so formed will normally be a cross-linked hydrophilic polyurethane foam.
  • the hydrophilicity of the foam is believed to be dependent on the oxyethylene groups. Varying the weight % of oxyethylene groups in the constituents of the blend, can provide the hydrophilic polyurethane foams of the invention with a wide range of water absorption properties.
  • the hydrophilic foam will absorb at least 5% by weight of its weight of water.
  • the water absorption of the hydrophilic polyurethane foams aptly range from 25% to 95% by weight of polymer.
  • Preferred hydrophilic polyurethane foams of the invention have a water absorption of 50% to 92% by weight of polymer.
  • the water absorption of the foam is determined by weighing a 1cm cube of the foam, then immersing the foam in water (at 20°C) for 24 hours, removing excess water by lightly blotting the foam with absorbent paper and then re-weighing the foam cube. The water absorption of the foam (% by weight) can then be calculated as
  • the hydrophilic polyurethane foam of the invention will normally be an open cell foam.
  • the open cell foam can suitably have a density of 20 to 350 Kg/m 3 and can preferably have a density of 4 to 150Kg/m 3 .
  • the hydrophilic polyurethane fo__n can be in a sheet, moulded or particulate form.
  • hydrophilic polyurethane foams of the invention can be used in absorptive devices for example as an absorbent component thereof.
  • the prepolymer forming reaction may be catalysed.
  • Suitable catalysts include Dioctyl tin dilaurate (Metatin 812 ES) ; dioctyl tin mercaptide ester (Metatin 813 and Metatin 713); cibutyl tin dilaurate (T-12); stannous octate (T-rt and Bismuth neodecanoate (Coscat 83).
  • the catalysts may be added in the range of 0.5 to O.OOlv/w %.
  • the aqueous phase may contain a catalyst to increase the rate of reaction.
  • a suitable amount of water required to be added to the prepolymer blend can be the stoichiometric amount of water needed to react with the NCO groups in the prepolymers. It is preferred, however, in order to obtain a homogenous mixture of water and prepolymers to use up to 12. eg. 4 to 10% by weight of water and preferably 5% by veight water in the process.
  • a suitable catalyst for the reaction is an alkali metal carbonate such as potassium carbonate which can be present in amounts of 0.5 to 1.5% by weight of the blend.
  • water or an aqueous solution will normally be provided in liquid form which is mixed and reacted with the prepolymer blend.
  • the water in the process can also be provided by a material such as a metal salt hydrate which releases water in liquid or vapour form when heated.
  • Suitable metal hydrates for use in the invention include Na,B 4 0 7 .10H 2 0, Na 2 S0 4 .10H 2 0, Na 2 Si0 3 .9H 2 0 and MgS0 4 .7H 2 0 which is preferred.
  • the metal salt hydrate which is preferably in particulate form is mixed into the prepolymer blend. The mixture can then be heated to a suitable temperature to release the water for reaction with the prepolymer blend.
  • the foam can be formed into a sheet or a desired shape by casting the foaming mixture into a release carrier or into a shaped mould and allowing the mixture to rise and set.
  • the foams produced by the process of the invention can then be incorporated into absorptive devices using conventional methods.
  • the hydrophilic foams of the present invention may be used in the preparation of first aid dressings since they can be used to form thin flexible and conformable sheets which are ideally suited for making such dressings.
  • the polyurethane foam composition of the invention may cast into first aid dressings, for example as disclosed in WO91/01706 and WO91/01707.
  • first aid dressings for example as disclosed in WO91/01706 and WO91/01707.
  • dressings may be cast to thicknesses of 0.5 to 20mm, more aptly from 0.75 to 4mm.
  • PPG Polyoxypropylene
  • PEG polyethylene oxide
  • Copolymer polyether triol (Voranol CP 1421) 1 equiv.
  • Tin catalyst 0.01 w/w%
  • the aliphatic prepolymer is synthesised by first heating the triols and mono ether in an oven at 60°C to melt them. The melted triols and monc ether are then added to a 700ml flange flask followed by the di-isocyanate. The flask is fitted with an air-driven anchor stirrer, a lid, a dry nitrogen blanket and placed in a water bath at 60 ⁇ C. The components are stirred vigourously until homogenous. The tin catlayst is added via a dipo ⁇ able syringe, while the contents of the flask are being stirred continuously. The water bath is adjusted to 90°C and the reaction is allowed to continue for 60 minutes until completion, as indicated by the subsiding exotherm. After completion, the prepolymer is poured while still warm into an air-tight jar.
  • the aromatic prepolymer is formed by following the same steps as indicated above for preparation of the aliphatic prepolymer, except that after adjusting the water bath to 90 ⁇ C, the reaction is allowed to proceed for 30 rather than 60 minutes.
  • the aliphatic and aromatic prepolymers are then blended. When a homogenous prepolymer blend is obtained the aqueous phase is added to effect foaming.
  • the foam formed possesses all the properties discussed above which render it ideally suited for use in absorptive devices, particularly first-aid dressings.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Materials Engineering (AREA)
  • Hematology (AREA)
  • Dispersion Chemistry (AREA)
  • Polyurethanes Or Polyureas (AREA)
  • Manufacture Of Porous Articles, And Recovery And Treatment Of Waste Products (AREA)

Abstract

A hydrophilic polyurethane foam for use in first aid dressings which comprises residues from an aromatic isocyanate prepolymer and an aliphatic isocyanate prepolymer and in which at least one of said prepolymers contains residues from polyether polyol. A process for the formation of the hydrophilic polyurethane and absorptive devices of hydrophilic polyurethane foam such as wound dressings and sanitary devices.

Description

POLYURETHANE FOAMS
The present invention relates to hydrophilic polyurethane foams, blends used to prepare these foams, absorptive devices comprising the foams and methods for their preparation.
There have been several proposals to the use of hydrophilic polyurethane foams, for example as an absorbent material, in hygienic and medical absorptive devices such as sanitary towels, tampons, diapers, incontinence pads and wound dressings. Hydrophilic polyurethane foams, however, are usually more expensive than the conventional cellulosic absorbent materials used in such devices and have therefore not been extensively used in commercial absorptive devices. British Patent No. 1429711 (see also United States Patent Nos. 3812618, 3812619, 3874694, 3889417, 3928138, 3929574 and 4137200) discloses a hydrophilic polyurethane foam formed by reacting with water an isocyanate capped polyoxyethylene glycol prepolymer.
It was found, however, that a large molar excess of water was required to obtain satisfactory foams. Removal of this excess water, for example, by drying, rendered these foams relatively expensive to manufacture. British Patent No. 2188055 discloses hydrophilic polyurethane foams formed by reacting with water the reaction product of polyisocyanate which has a functionality of greater than 2 and polyalkylene glycol mono alkyl or alkaryl ether. These prepolymers require to be mixed with only relatively low aaounts of water, thus obviating the need for an elaborate drying stage. The foams are therefore more economical to manufacture than previously known hydropilic foans.
The reaction rates of aliphatic isocyanate based polyurethane foam systems tend to be undesirably slow for commerical use unless high levels of ethylene oxide containing residues are incorporated into the reactive system.
The presence of high levels of such residues increases the linear swell value of the foam when hydrated. Whilst this effect may not be deleterious for foam products such as tampons or sanitary towels, high linear swell will adversely affect thin foam products such as wound dressings and in particular dressings such as first aid dressings.
Such dressings need to be able to absorb aqueous materials such as wound exudate and to be produced quickly and economically to compare favourably with conventional fabric and pad dressings.
The present invention seeks to provide a polyurethane foam which is hydrophilic and has good dimensional stability when produced in thin flat sheets and which can be produced rapidly and economically.
Accordingly the present invention provides a polyurethane hydrophilic foam, suitable for use as first aid dressing which and comprise residues of a aromatic isocyanate, of an aliphatic isocyanate, of a polyoxyalkylene monoether and of a polyoxyalkylene polyol such as a polyether polyol.
In another aspect the present invention further provides an absorptive device which comprises a hydrophilic polyurethane foam of the invention. The absorptive device of the invention is preferably a medical or hygienic device such as a vound dressing eg. a first aid dressing, sanitary towel, diaper, incontinence pad tampon, or the like.
In a further aspect the invention provides a process for preparing a hydrophilic polyurethane foam of the invention which comprises blending at least one aromatic based prepolymer with at least one aliphatic based prepolymer. An aqueous phase is then added to effect the foaming reaction and the foam formed is allowed to set.
According to an embodiment of the present invention there is provided a hydrophilic polyurethane foam comprising residues of a first isocyanate prepolymer derived from a polyoxyalkylene mono ether and an aromatic isocyanate containing at least two isocyanate groups and residues of a second isocyanate prepolymer derived from a polyoxyalkylene mono ether and an aliphatic isocyanate containing at least two isocyanate groups and in which at least one of said isocyanate prepolymers contains residues from a polyether polyol.
The present invention also provides a hydrophilic polyurethane foam formed by blending at least one of said aromatic isocyanate based prepolymers and at least one aliphatic isocyanate based prepolymers and subsequently adding an aqeous phase to catalyse the foaming reaction wherein at least one of the prepolymers is additionally derived from a polyether polyol .
According to the process of the present invention, control over a wider range of processing variables and foam properties can be achieved than was hitherto possible.
Processing variables which may re controlled more readily than was previously possible include efficiency of mixing and ease of dispensing, cre≥m time, rise time, gel time and cure time.
Foam properties which may be controlled more readily according to the process of tie invention include softness and resiliency, density, cell size and structure, water content and capacity, linear swell on hydration and rate of wicking.
These properties may be achieved by blending the prepolymers over a wide range of ratios of the aromatic based prepolymer to the aliphatic based prepolymer properties. Thus foams displaying excellent water uptake, water capacity and strength have been found. The foams also possess a lower level of extractables. Furthermore they can be formed into tiin sheets which show excellent conformability.
Suitably the prepolymer blend should contain at least 10w/w% of the solids weight of aliphatic based prepolymer. Similarly it has been fc_nd that the blend should contain at least 10w/w% of the solids weight of aromatic based prepolymer. Aptly the ratio of aromatic isocyanate to aliphatic isocyanate prepolymers will be from 25-75 to 75:25 weight percent. More aptly the ratio of prepolymers will be about 50:50 weight percent.
The hydrophilic polyurethane foams of the invention can be formed by mixing the blend with a stoichiometric amount of water. It is preferred, however, to mix the blend with a low molar excess of water for example 10% by weight of water. It has been found that this low molar excess of water can be easily absorbed by the hydrophilic foam.
Suitable polyoxyalkylene mono ethers for preparing the prepolymer components of the blend of the present invention, may be polyoxyalkylene monoalkyl or monoalkaryl ethers. Preferably the mono ethers are polyalkylene glycol monoethers.
The alkylene moiety of the mono ethers may contain 1 to 4 carbons.
Preferred polyalkylene glycol mono alkaryl ethers are those in which the alkylene group is ethylene.
Suitable polyalkylene glycol mono alkaryl ethers include those in which the a-ryl moeity is phenyl. Preferred ethers are those in which the alkyl moeity contains from 1 to 20 carbon atoms eg. octyl or nonyl.
Suitable polyalkylene glycol mono alkyl ethers for forming the reaction product are those in which the alkyl group contains 1 to 20 carbon atoms. Alkylene favoured ethers are those in which the alkyl group is a methyl group. Another class of preferred polyalkylene glycol mono alkyl ethers are those in which the alkyl group contains 10 to 18 carbon atoms, eg. lauryl or cetyl.
Preferred polyalkylene glycol mono alkyl ethers are those in which the alkylene group is ethylene.
The polyalkylene glycol alkyl or alkaryl ether can suitably have an average molecular weight of 180 to 6000.
Apt ethers are polyethylene glycol mono lauryl ethers having an average molecular weight of approximately 1090 and 360 known as Brij 35 and Brij 30 respectively, available from Honeywell Atlas and polyethylene glycol mono methyl ethers having an average molecular weight of approximately 500 and 5000 known as PEG monomethylether molecular weight 550 and 5000 respectively, available from Aldrich Chemicals.
Suitable polyethylene glycol mono nonyl phenyl ethers are commercially available under the Trade names Antarox CO-320, Antarox Co-990, available from GAF (Great Britain) Co. Ltd. Apt polyethylene glycol mono nonyl phenyl ethers, are Dowafax 9N6 and 9N20 having an average molecular wieght in the range of 400-500 and 1100-1200 respectively and available from K+K Greeft Ltd. Typically the ethylene oxide molecular weight can vary in the range 220 to 2200.
The polyethylene glycol mono alkyl or alkaryl ether used in the invention will normally contain water. It is preferred, however, that the ether contains less than 1% by weight water, to limit the number of urea groups formed in the reaction with the polyisocyanate during the prepolymer formulation.
The polyether polyol residues present in at least one of the blend prepolymers, may be derived from polyhydric alcohols, alkylene polyamines, alkylene amines, cyclic amines, amides and polycarboxylic acids. In addition suitable polyols may be derived from hydrophilic reactantε. A particularly suitable hydrophilic reactant is ethylene oxide. Preferred polyether polyols are derived from ethylene oxide and aliphatic polyhydric alcohols. Suitable alcohols may have from 2 to £ carbon atoms eg. ethylene glycol, pentaerythritol, procylene glycol, 2,3-butylene glycol, glycerol, 1,5-per.oanediol and the like.
The polyether polyols may be derived from the polymerisation of ethylene oxide in _____ presence of the above mentioned di- or polyfunctional reactants.
Particularly suitable polyether polyols for the preparation of foams of the present invention are polyether triols. Preferred polyether triols are polyoxypropylene (PPG) ether triols, end-capped with polyethylene oxide (PEG). Suitably the PEG may comprise 2 to 30w/w% of the polyether triol. Typically the PEG comprises 5 to 15w/w% of the rolyether.
Apt polyoxypropylene ether triols, end-capped with PEG have an average molecular weight of 700 to 7000. Typically the PPG ether triols, end capped with PEG will have an average molecular weight in the range of 3000-3500 eg. Arcol 132 available from Arco Chemical Products Europe.
At least one of the blend prepclymers may further be derived from a copolymer polyether triol derived from the polyether polyols described herein. A particularly preferred copolymer polyether is based on PPG and PEG blocks. Suitably the PEG may be present in the range of 40 to 75w/w of the copoljmer. More suitably the PEG may comprise 45-55w/v%. Preferably the PEG comprises 45w/w% of the copolymer. A preferred copolymer polyether is Voranol CP1421 which has an average molecular weight in the range of 3000-3500 and is supplied by Dow Chemicals Europe.
The ratio of triol equivalents _o mono ether equivalents may be varied to alter the processing variables and the foam properties. It has been found that suitably the ratio of triol equivalents to mono ether equivalents is in the range of 1.3:1 to 10:1, more suitably from 1:1 to 5:1 and preferably about 3:1.
The iεocyanates used for forming the blend prepolymers will have a functionality of at least 2. Suitably both the aliphatic aromatic isocyanates will have a functionality of less than about 2.5.
Suitable aliphatic polyisocyanates for use in the invention include 4 , 4 '-dicyclohexyl nethane di-isocyanate (Desraodur W) which has a functionality of 2.0 and is available from Bayer A.G. and hexamethylene di-isocyanate.
Suitable aromatic isocyanates for forming the blend prepolymers are polymeric methylene di-isocyanates. Polymeric methylene di-isocyanates comprise a mixture of 4,4'-diphenyl methane diisocyanates and one or more of polyaeric homologues. Apt polymeric methylene di-isocyanates are known as suprasec VM 10, VM 20 and VM 50 available from ICI and have a functionality of 2.07, 2.13 and 2.49 respectively. Further aromatic isocyanates which may be used include toluene di-isocyanate, methylene-bis-( 4-phenyl isocyanate) , 3,3'-bitolylene-4,4'-di-isocyanate, 1,4-phenylene di-isocyanate, naphthalene-1,5-*-di-isocγanate and the like.
A favoured blend for forming foams of the present invention comprises an aliphatic based prepolymer derived from polyoxyethylene glycol rβono-nonyl phenyl ether, a polyoxypropylene ether triol, end-capped with PEG, a copolymer poplyether triol and 4,4'-dicyclohexyl methane di-isocyanate (Desmσdur W) . The blend further comprises an aromatic based prepolymer derived from a polyoxyethylene gylcol mono-nonyl phenyl ether, a polyoxypropylene ether triol, end-capped with PEG and a polymeric methylene di-isocyanate comprising a mixture of , '-diphenyl methane di-isocyanate and one or more polymeric homologues.
In forming the prepolymers, the isocyanate and reactive hydrogen containing compound are present in an amount to ensure that the prepolymers contain an excess of isoycanate groups. Aptly the isocyanate to hydroxyl ratio (NCO:OH) is at least 2:1. Suitably the NCO:OH ratio should be less than 6:1. Typically the NCO:OH ratio is in the range of 2.7:1 and 4:1.
The prepolymers employed in the invention contain an excess of isocyanate groups. Suitably they contain an excess of at least 2 w/w% NCO groups, more suitably upto 12%w/w excess NCO groups. Typically the prepolymers contain an excess of 5 tc 7w/w% NCO groups.
Normally the mono ethers and pclyols will be pre-dried to a water content of less than 1%.
The blend can be reacted with an aqueous phase to form a hydrophilic polyurethane foam of the invention. The hydrophilic polyurethane so formed will normally be a cross-linked hydrophilic polyurethane foam. The hydrophilicity of the foam is believed to be dependent on the oxyethylene groups. Varying the weight % of oxyethylene groups in the constituents of the blend, can provide the hydrophilic polyurethane foams of the invention with a wide range of water absorption properties. Suitably the hydrophilic foam will absorb at least 5% by weight of its weight of water. The water absorption of the hydrophilic polyurethane foams aptly range from 25% to 95% by weight of polymer. Preferred hydrophilic polyurethane foams of the invention, however, have a water absorption of 50% to 92% by weight of polymer.
The water absorption of the foam is determined by weighing a 1cm cube of the foam, then immersing the foam in water (at 20°C) for 24 hours, removing excess water by lightly blotting the foam with absorbent paper and then re-weighing the foam cube. The water absorption of the foam (% by weight) can then be calculated as
weight of wet foam (g) - weight of dry foam (g) x 100 weight of wet foam
The hydrophilic polyurethane foam of the invention will normally be an open cell foam. The open cell foam can suitably have a density of 20 to 350 Kg/m3 and can preferably have a density of 4 to 150Kg/m3. The hydrophilic polyurethane fo__n can be in a sheet, moulded or particulate form.
The hydrophilic polyurethane foams of the invention can be used in absorptive devices for example as an absorbent component thereof.
If desired, the prepolymer forming reaction may be catalysed. Suitable catalysts include Dioctyl tin dilaurate (Metatin 812 ES) ; dioctyl tin mercaptide ester (Metatin 813 and Metatin 713); cibutyl tin dilaurate (T-12); stannous octate (T-rt and Bismuth neodecanoate (Coscat 83). Suitably the catalysts may be added in the range of 0.5 to O.OOlv/w %.
Suitably the aqueous phase may contain a catalyst to increase the rate of reaction.
It has been found that a suitable amount of water required to be added to the prepolymer blend can be the stoichiometric amount of water needed to react with the NCO groups in the prepolymers. It is preferred, however, in order to obtain a homogenous mixture of water and prepolymers to use up to 12. eg. 4 to 10% by weight of water and preferably 5% by veight water in the process. A suitable catalyst for the reaction is an alkali metal carbonate such as potassium carbonate which can be present in amounts of 0.5 to 1.5% by weight of the blend.
In the process of the invention water or an aqueous solution will normally be provided in liquid form which is mixed and reacted with the prepolymer blend. The water in the process, however, can also be provided by a material such as a metal salt hydrate which releases water in liquid or vapour form when heated. Suitable metal hydrates for use in the invention include Na,B407.10H20, Na2S04.10H20, Na2Si03.9H20 and MgS04.7H20 which is preferred. In the process the metal salt hydrate which is preferably in particulate form is mixed into the prepolymer blend. The mixture can then be heated to a suitable temperature to release the water for reaction with the prepolymer blend.
The foam can be formed into a sheet or a desired shape by casting the foaming mixture into a release carrier or into a shaped mould and allowing the mixture to rise and set.
The foams produced by the process of the invention can then be incorporated into absorptive devices using conventional methods. In particular the hydrophilic foams of the present invention may be used in the preparation of first aid dressings since they can be used to form thin flexible and conformable sheets which are ideally suited for making such dressings.
Aptly the polyurethane foam composition of the invention may cast into first aid dressings, for example as disclosed in WO91/01706 and WO91/01707. Suitably such dressings may be cast to thicknesses of 0.5 to 20mm, more aptly from 0.75 to 4mm.
The invention will now be illustrated by reference to the following example:
ALIPHATIC PREPOLYMER FORMULATION
Polyoxypropylene (PPG) ether triol, 2 equiv. polyethylene oxide (PEG) end-capped (Arcol 1132)
Polyoxyethylene mono-nonyl phenyl 1 equiv. ether (Dowfax 9N20)
Copolymer polyether triol (Voranol CP 1421) 1 equiv.
4,4'-dicyclohexylmethane di-isocyanate (Desmodur W) to give an NCO:OH ratio of 3.0:1.
Tin catalyst
(Metatin 812ES, Acima Chemicals Ltd) 0.05 w/w%
AROMATIC PREPOLYMER FORMULATION
Arcol 1132 2 equiv
Polyoxyethylene mono-nonyl phenyl ether 1 equiv. (Dowfax 9N6)
Methylene diphenyl di-isocyanate (VM10) to give an NCO:OH ratio of 3.5:1
Tin catalyst (Metatin 812ES) 0.01 w/w% The aliphatic prepolymer is synthesised by first heating the triols and mono ether in an oven at 60°C to melt them. The melted triols and monc ether are then added to a 700ml flange flask followed by the di-isocyanate. The flask is fitted with an air-driven anchor stirrer, a lid, a dry nitrogen blanket and placed in a water bath at 60βC. The components are stirred vigourously until homogenous. The tin catlayst is added via a dipoεable syringe, while the contents of the flask are being stirred continuously. The water bath is adjusted to 90°C and the reaction is allowed to continue for 60 minutes until completion, as indicated by the subsiding exotherm. After completion, the prepolymer is poured while still warm into an air-tight jar.
The aromatic prepolymer is formed by following the same steps as indicated above for preparation of the aliphatic prepolymer, except that after adjusting the water bath to 90βC, the reaction is allowed to proceed for 30 rather than 60 minutes.
The aliphatic and aromatic prepolymers are then blended. When a homogenous prepolymer blend is obtained the aqueous phase is added to effect foaming. The foam formed possesses all the properties discussed above which render it ideally suited for use in absorptive devices, particularly first-aid dressings.

Claims

- 20 -Claims
1. A hydrophilic polyurethane foam, vhich comprises residues of an aromatic isocyanate, an aliphatic isocyanate, a polyoxyalkylene mono ether and a polyether polyol.
2. A hydrophilic polyurethane foam, which comprises residues of a first isocyanate prepolymer derived from a polyoxyalkylene mono ether and an aromatic isocyanate containing at least two isocyanate groups and residues of a second isocyanate prepolymer derived from a polyoxyalkylene mono ether and an aliphatic isocyanate containing at least two isocyanate groups and in which at least one of said prepolymers contains residues from a polyether polyol.
3. A foam according to claim 1, wherein the polyether polyol is a polyoxyalkylene polyol.
4. A foam according to any of claims 1 to 3, wherein the polyether polyol residues in at least one of the blend prepolymers is derived from hydrophilic reactants. - 21 -
5. A foam according to any of claims 1 to 4, wherein the polyol residues are polyether triols.
6. A foam according to claim 5, wherein the polyether triol is polyoxypropylene (PPG) ether triols, end-capped with polyethylene oxide (PEG).
7. A foam according to claim 6, wherein the PEG comprises between 2 to 30 w/w% of polyether triol.
8. A foam according to claim 6 or claim 7, wherein the PPG ether triol, end-capped with PEG has a molecular weight between 700 to 7000.
9. A foam according to any of claims 6 to 8, wherein the PEG is present between the ranges of 40 to 75 w/w% of copolymer.
10. A foam according to any of the preceding claims, wherein the ratio of polyol equivalents to mono ether equivalents is between 1.3:1 to 10:1.
11. A foam according to any of the preceding claims, wherein the isocyanates have a functionality of at least 2.
12. A foam according to any one of claims 2 to 11, wherein the aliphatic based prepolymer is derived from polyoxyethylene glycol mono-nonyl phenyl ether, a polyoxypropylene ether triol, end-capped with PEG, a copolymer polyether triol and an aliphatic di-isocyanate.
13. A foam according to claims 2 to 12, wherein the aromatic based prepolymer is derived from a polyoxyethylene glycol mono-nonyl phenyl ether, a polyoxypropylene ether triol, end-capped with PEG and a polyermic methylene di-isocyanate.
14. A foam according to any of claims 2 to 13, wherein the prepolymers contain an excess of isocyanate groups.
15. A foam according to claim 14, wherein the prepolymers contain an excess of at least 2 w/w% NCO groups.
16. A process for the preparation of a hydrophilic polyurethane foam which comprises reacting at least one of each of an aromatic isocyanate, an aliphatic isocyanate, a polyoxyalkylene mono ether and a polyether polyol to form a foam precursor and thereafter foaming the precursor.
17. A process according to claim 16, in which the foam precursor is a single prepolymer derived from an aromatic isocyanate, an aliphatic isocyanate, a polyoxyalkylene mono ether and a polyether polyol.
18. A process according to claim 16, in which the foam precursor comprises a mixture of isocyanate prepolymers derived from the aromatic isocyanate, the aliphatic isocyanate, the polyoxyalkylene mono ether and the polyether polyol.
19. A process for the preparation of hydrophilic polyurethane foam comprising the steps of:-
- blending at least a first isocyanate based prepolymer and at least a second isocyanaite based prepolymer
- adding an aqueous foaming phase wherein at least one of the prepolymers is derived from polyoxyalkylene polyol.
20. A process according to claim 19, wherein the prepolymer blend contains at least 10 w/w% of solids weight of the first isocyanate based prepolymer and 10 w/w% of solids weight of the second isocyanate based prepolymer.
21. A process according to claim 19 or 20, wherein the ratio of the first isocyanate based prepolymer to the second isocyanate prepolymer is between 25:75 to 75:25 weight per cent.
22. Process according to any of claims 19 to 21, wherein the prepolymer blend is mixed with 10% by weight of water.
23. A foam produced by the process as claimed in any of claims 16 to 22 and having a composition as claimed in any of claims 1 to 15.
24. An absorptive device comprising a foam as claimed in any of claims 1 to 15.
25. An absorptive device according to claim 24 in the form of a first aid dressing.
PCT/GB1992/001527 1991-08-20 1992-08-19 Polyurethane foams WO1993004101A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GB9400982A GB2273296B (en) 1991-08-20 1992-08-19 Polyurethane foams
AU24404/92A AU656997B2 (en) 1991-08-20 1992-08-19 Polyurethane foams
EP92917631A EP0599932A1 (en) 1991-08-20 1992-08-19 Polyurethane foams
JP5504197A JPH06510312A (en) 1991-08-20 1992-08-19 polyurethane foam

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919117913A GB9117913D0 (en) 1991-08-20 1991-08-20 Polyurethane foams
GB9117913.5 1991-08-20

Publications (1)

Publication Number Publication Date
WO1993004101A1 true WO1993004101A1 (en) 1993-03-04

Family

ID=10700213

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB1992/001527 WO1993004101A1 (en) 1991-08-20 1992-08-19 Polyurethane foams

Country Status (8)

Country Link
EP (1) EP0599932A1 (en)
JP (1) JPH06510312A (en)
AU (1) AU656997B2 (en)
CA (1) CA2114411A1 (en)
GB (2) GB9117913D0 (en)
MX (1) MX9204833A (en)
WO (1) WO1993004101A1 (en)
ZA (1) ZA926233B (en)

Cited By (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4328190A1 (en) * 1993-08-23 1995-03-02 Beiersdorf Ag Wound care articles with selective absorbency
US6914117B2 (en) 2001-05-21 2005-07-05 Huntsman International Llc Elastomeric polyurethane material
EP2289959A1 (en) * 2009-08-29 2011-03-02 Bayer Material Science AG Hydrophilic aliphatic polyurethane foams
EP2471830A1 (en) * 2009-09-18 2012-07-04 Asahi Glass Company, Limited Process for production of flexible polyurethane foam
WO2012140377A1 (en) 2011-04-15 2012-10-18 Laboratoires Urgo Hydrocellular absorbent dressing, and uses thereof for the treatment of chronic and acute wounds
WO2013007973A2 (en) 2011-07-14 2013-01-17 Smith & Nephew Plc Wound dressing and method of treatment
US8741977B2 (en) 2007-03-13 2014-06-03 Avery Dennison Corporation Foam compositions and articles including cyclodextrin crosslinked with polyurethane prepolymer and preparation thereof
WO2014147339A1 (en) 2013-03-20 2014-09-25 Laboratoires Urgo Dressing having an adhesive peripheral edge with an undulating circumference
WO2015041905A1 (en) * 2013-09-20 2015-03-26 Sabic Global Technologies B.V. Polyurethane foam and associated method and article
US9169368B2 (en) 2013-07-30 2015-10-27 Sabic Global Technologies B.V. Rigid foam and associated article
US9422394B2 (en) 2013-06-28 2016-08-23 Sabic Global Technologies B.V. Thermoplastic polyurethane and associated method and article
US9597234B2 (en) 2011-04-15 2017-03-21 Urgo Recherche Innovation Et Development Very absorbent, thin adhesive dressing, and uses thereof for the treatment of chronic wounds
WO2018055278A1 (en) 2016-09-20 2018-03-29 Urgo Recherche Innovation Et Developpement Absorbent dressing comprising a water-disintegratable superabsorbent nonwoven
WO2020104426A1 (en) 2018-11-19 2020-05-28 T.J.Smith And Nephew,Limited Absorbent component
WO2020104427A1 (en) 2018-11-19 2020-05-28 T.J.Smith And Nephew,Limited Absorbent yarn
WO2021032713A1 (en) 2019-08-22 2021-02-25 T.J.Smith And Nephew,Limited Absorbent component
WO2021032720A1 (en) 2019-08-22 2021-02-25 T.J.Smith And Nephew,Limited Wound dressing
WO2023166262A1 (en) 2022-03-03 2023-09-07 Urgo Recherche Innovation Et Developpement Adjustable dressing

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE670906A (en) * 1964-10-14 1966-04-14
US3457203A (en) * 1966-04-25 1969-07-22 Olin Mathieson Hydrophilic polyurethane foams and a process for preparing them
US4292412A (en) * 1980-01-16 1981-09-29 W. R. Grace & Co. Hydrophilic, fabric softener foam compositions and method of making
US4439553A (en) * 1983-01-17 1984-03-27 W. R. Grace & Co. High molecular weight aromatic amine scavengers and method of use
EP0299122A1 (en) * 1987-07-17 1989-01-18 SMITH & NEPHEW plc Hydrophilic polyurethane foams

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0299112B1 (en) * 1987-07-15 1992-04-15 Proni Creations Inc. A force concentrating unitary fitting

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE670906A (en) * 1964-10-14 1966-04-14
US3457203A (en) * 1966-04-25 1969-07-22 Olin Mathieson Hydrophilic polyurethane foams and a process for preparing them
US4292412A (en) * 1980-01-16 1981-09-29 W. R. Grace & Co. Hydrophilic, fabric softener foam compositions and method of making
US4439553A (en) * 1983-01-17 1984-03-27 W. R. Grace & Co. High molecular weight aromatic amine scavengers and method of use
EP0299122A1 (en) * 1987-07-17 1989-01-18 SMITH & NEPHEW plc Hydrophilic polyurethane foams

Cited By (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4328190A1 (en) * 1993-08-23 1995-03-02 Beiersdorf Ag Wound care articles with selective absorbency
US6914117B2 (en) 2001-05-21 2005-07-05 Huntsman International Llc Elastomeric polyurethane material
US8741977B2 (en) 2007-03-13 2014-06-03 Avery Dennison Corporation Foam compositions and articles including cyclodextrin crosslinked with polyurethane prepolymer and preparation thereof
US9228048B2 (en) 2007-03-13 2016-01-05 Avery Dennison Corporation Foam compositions and articles including cyclodextrin crosslinked with polyurethane prepolymer and preparation thereof
EP2289959A1 (en) * 2009-08-29 2011-03-02 Bayer Material Science AG Hydrophilic aliphatic polyurethane foams
WO2011023762A3 (en) * 2009-08-29 2011-11-03 Bayer Materialscience Ag Hydrophilic aliphatic polyurethane foams
US8980966B2 (en) 2009-08-29 2015-03-17 Bayer Materialscience Ag Hydrophilic aliphatic polyurethane foams
EP2471830A1 (en) * 2009-09-18 2012-07-04 Asahi Glass Company, Limited Process for production of flexible polyurethane foam
EP2471830A4 (en) * 2009-09-18 2014-05-07 Asahi Glass Co Ltd Process for production of flexible polyurethane foam
WO2012140377A1 (en) 2011-04-15 2012-10-18 Laboratoires Urgo Hydrocellular absorbent dressing, and uses thereof for the treatment of chronic and acute wounds
US9452086B2 (en) 2011-04-15 2016-09-27 Laboratoires Urgo Hydrocellular absorbent dressing, and uses thereof for the treatment of chronic and acute wounds
US9597234B2 (en) 2011-04-15 2017-03-21 Urgo Recherche Innovation Et Development Very absorbent, thin adhesive dressing, and uses thereof for the treatment of chronic wounds
WO2013007973A2 (en) 2011-07-14 2013-01-17 Smith & Nephew Plc Wound dressing and method of treatment
EP3508182A1 (en) 2011-07-14 2019-07-10 Smith & Nephew PLC Wound dressing and method of treatment
WO2014147339A1 (en) 2013-03-20 2014-09-25 Laboratoires Urgo Dressing having an adhesive peripheral edge with an undulating circumference
US9422394B2 (en) 2013-06-28 2016-08-23 Sabic Global Technologies B.V. Thermoplastic polyurethane and associated method and article
US9169368B2 (en) 2013-07-30 2015-10-27 Sabic Global Technologies B.V. Rigid foam and associated article
US9266997B2 (en) 2013-09-20 2016-02-23 Sabic Global Technologies B.V. Polyurethane foam and associated method and article
WO2015041905A1 (en) * 2013-09-20 2015-03-26 Sabic Global Technologies B.V. Polyurethane foam and associated method and article
WO2018055278A1 (en) 2016-09-20 2018-03-29 Urgo Recherche Innovation Et Developpement Absorbent dressing comprising a water-disintegratable superabsorbent nonwoven
WO2020104426A1 (en) 2018-11-19 2020-05-28 T.J.Smith And Nephew,Limited Absorbent component
WO2020104427A1 (en) 2018-11-19 2020-05-28 T.J.Smith And Nephew,Limited Absorbent yarn
WO2021032713A1 (en) 2019-08-22 2021-02-25 T.J.Smith And Nephew,Limited Absorbent component
WO2021032720A1 (en) 2019-08-22 2021-02-25 T.J.Smith And Nephew,Limited Wound dressing
WO2023166262A1 (en) 2022-03-03 2023-09-07 Urgo Recherche Innovation Et Developpement Adjustable dressing
FR3133122A1 (en) 2022-03-03 2023-09-08 Urgo Recherche Innovation Et Developpement Modular dressing

Also Published As

Publication number Publication date
MX9204833A (en) 1993-03-01
JPH06510312A (en) 1994-11-17
AU2440492A (en) 1993-03-16
GB2273296A (en) 1994-06-15
CA2114411A1 (en) 1993-03-04
EP0599932A1 (en) 1994-06-08
ZA926233B (en) 1994-03-18
AU656997B2 (en) 1995-02-23
GB9117913D0 (en) 1991-10-09
GB2273296B (en) 1995-05-24
GB9400982D0 (en) 1994-03-16

Similar Documents

Publication Publication Date Title
WO1993004101A1 (en) Polyurethane foams
US5164421A (en) Hydrophilic polyurethane foams
EP0086621B1 (en) Polyurethane casting material
EP0299122B1 (en) Hydrophilic polyurethane foams
CA1263998A (en) Hydrophilic, flexible, open cell polyurethane poly (n- vinyl lactam) interpolymer foam and dental and biomedical products fabricated therefrom
US5296518A (en) Hydrophilic polyurethaneurea foams containing no toxic leachable additives and method to produce such foams
US3903232A (en) Dental and biomedical foams and method
US3778390A (en) Hydrolytically unstable polyurethane foams
JP3012300B2 (en) Water-absorbent, high-capacity polyurethane foam
CA1175596A (en) Hydrophilic polyurethane diacrylate composition
US5489620A (en) Process for making flexible foams
CA2730025A1 (en) Hydrophilic, aliphatic polyurethane foams
GB2188055A (en) Hydrophilic polyurethane foams
JP2702772B2 (en) Method for producing molded article of water-absorbing polyurethane foam
KR100345034B1 (en) Manufacturing method of dressing agent for wound healing
CN114560988A (en) High-comfort polyurethane sponge, preparation method and application product thereof
EP0328531B1 (en) Bandages
US10988565B2 (en) Process for producing elastic and tear-resistant polyurethane foams and uses
US3809088A (en) Hydrolytically unstable polyurethane cotamenial devices
EP0414701B1 (en) Orthopaedic material of isocyanate resin
US5763682A (en) Hydrophilic polyol and process for production thereof
US4654234A (en) Polyurethane foam for cleaning and germicidal applications
WO2022073834A1 (en) Method for producing polyurethane foams or hydrogels by employing diol containing formulations

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AT AU BB BG BR CA CH CS DE DK ES FI GB HU JP KP KR LK LU MG MN MW NL NO PL RO RU SD SE US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL SE BF BJ CF CG CI CM GA GN ML MR SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 1992917631

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2114411

Country of ref document: CA

ENP Entry into the national phase

Ref document number: 1994 196124

Country of ref document: US

Date of ref document: 19940218

Kind code of ref document: A

WWP Wipo information: published in national office

Ref document number: 1992917631

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 1992917631

Country of ref document: EP